Skip to main content
Caplight Logo









Perifit

Perifit

Private
ParisHealthcare & Life Scienceshttps://perifit.co

Last Round

Crowdfunding

Apr 19, 2018

Total Funding Raised

$110,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Perifit operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Crowdfunding round in April 2018.

Perifit is a healthtech company that provides a training device and app for strengthening the pelvic area of women.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Health IoT, Sports & Fitness, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Perifit Comparables

Compare Perifit with similar companies based on industry and business-model similarity.

Perifit comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fizimed
86%
Minna Life
84%
Junofem
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Perifit Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingApr 19, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Robin Reynaud

Chief Technology Officer

Executive Team

Stéphanie Woringer

COO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 49, 66% of headcount.

  • Jul 20, 2026

    Open roles increased to 49, 66% of headcount.

Book a demo to see all signals

For institutional investors. Book with your work email.

Perifit Filings

Explore SEC and related filing metadata, where available.

Perifit filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Perifit's valuation, stock price, and market status.

Is Perifit a public or private company?

Perifit is a private company.

What is the current stock price of Perifit?

Perifit is a private company, so its shares have no public market price. Caplight tracks Perifit's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Perifit worth (valuation)?

Valuation information for Perifit is not publicly available.

Can I buy Perifit stock?

Perifit shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Perifit's last funding round?

Perifit's most recent funding round was Crowdfunding on April 19, 2018.

Who are the main investors in Perifit?

Investor information for Perifit is not publicly disclosed.

Will Perifit IPO soon?

No public IPO plans have been announced for Perifit.

How can I track Perifit secondary market activity?

Caplight tracks bids, offers, and trades in Perifit's shares on secondary markets.

Firmographic Details

HeadquartersParis
Employee Range59
Year Founded2016
Last FundingApr 19, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?